Skip to Main Content

Author Details

Jane B Lian
University of Vermont
1973
588
112
PMIDPaper TitleJournal TitlePublished Year
38073442Bromodomain Proteins Epigenetically Regulate the Mitotically Associated lncRNA MANCR in Triple Negative Breast Cancer Cells.Crit Rev Eukaryot Gene Expr2024
38073442Bromodomain Proteins Epigenetically Regulate the Mitotically Associated lncRNA MANCR in Triple Negative Breast Cancer Cells.Crit Rev Eukaryot Gene Expr2024
37094694Spatiotemporal higher-order chromatin landscape of human histone gene clusters at histone locus bodies during the cell cycle in breast cancer progression.Gene2023
37985890LINC01638 sustains human mesenchymal stem cell self-renewal and competency for osteogenic cell fate.Sci Rep2023
37094694Spatiotemporal higher-order chromatin landscape of human histone gene clusters at histone locus bodies during the cell cycle in breast cancer progression.Gene2023
37017672Spatiotemporal Epigenetic Control of the Histone Gene Chromatin Landscape during the Cell Cycle.Crit Rev Eukaryot Gene Expr2023
37178577Corrigendum to "Spatiotemporal higher-order chromatin landscape of human histone gene clusters at histone locus bodies during the cell cycle in breast cancer progression" [Gene 872 (2023) 147441].Gene2023
37048137Cbfβ Is a Novel Modulator against Osteoarthritis by Maintaining Articular Cartilage Homeostasis through TGF-β Signaling.Cells2023
37985890LINC01638 sustains human mesenchymal stem cell self-renewal and competency for osteogenic cell fate.Sci Rep2023
37048137Cbfβ Is a Novel Modulator against Osteoarthritis by Maintaining Articular Cartilage Homeostasis through TGF-β Signaling.Cells2023
37017672Spatiotemporal Epigenetic Control of the Histone Gene Chromatin Landscape during the Cell Cycle.Crit Rev Eukaryot Gene Expr2023
37178577Corrigendum to "Spatiotemporal higher-order chromatin landscape of human histone gene clusters at histone locus bodies during the cell cycle in breast cancer progression" [Gene 872 (2023) 147441].Gene2023
35012895Titanium with nanotopography attenuates the osteoclast-induced disruption of osteoblast differentiation by regulating histone methylation.Biomater Adv2022
35862394Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells.PLoS One2022
35730929Pathogenic mutations in the chromokinesin KIF22 disrupt anaphase chromosome segregation.Elife2022
35922466MicroRNA-101a enhances trabecular bone accrual in male mice.Sci Rep2022
36054037Sustained Morphine Delivery Suppresses Bone Formation and Alters Metabolic and Circulating miRNA Profiles in Male C57BL/6J Mice.J Bone Miner Res2022
35012895Titanium with nanotopography attenuates the osteoclast-induced disruption of osteoblast differentiation by regulating histone methylation.Biomater Adv2022
35730929Pathogenic mutations in the chromokinesin KIF22 disrupt anaphase chromosome segregation.Elife2022
35862394Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells.PLoS One2022
35922466MicroRNA-101a enhances trabecular bone accrual in male mice.Sci Rep2022
36054037Sustained Morphine Delivery Suppresses Bone Formation and Alters Metabolic and Circulating miRNA Profiles in Male C57BL/6J Mice.J Bone Miner Res2022
33748969Hypoxia-inducible factor 2α is a novel inhibitor of chondrocyte maturation.J Cell Physiol2021
33748969Hypoxia-inducible factor 2α is a novel inhibitor of chondrocyte maturation.J Cell Physiol2021
31919859Identification of tRNA-derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancer.J Cell Physiol2020
31907922Ezh2-dependent H3K27me3 modification dynamically regulates vitamin D3-dependent epigenetic control of CYP24A1 gene expression in osteoblastic cells.J Cell Physiol2020
31868234Switches in histone modifications epigenetically control vitamin D3-dependent transcriptional upregulation of the CYP24A1 gene in osteoblastic cells.J Cell Physiol2020
31919859Identification of tRNA-derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancer.J Cell Physiol2020
31907922Ezh2-dependent H3K27me3 modification dynamically regulates vitamin D3-dependent epigenetic control of CYP24A1 gene expression in osteoblastic cells.J Cell Physiol2020
31868234Switches in histone modifications epigenetically control vitamin D3-dependent transcriptional upregulation of the CYP24A1 gene in osteoblastic cells.J Cell Physiol2020
30443977Ethyl acetate and n-butanol fraction of Cissus quadrangularis promotes the mineralization potential of murine pre-osteoblast cell line MC3T3-E1 (sub-clone 4).J Cell Physiol2019
30030171Gut-derived serotonin contributes to bone deficits in colitis.Pharmacol Res2019
30256410Mll-COMPASS complexes mediate H3K4me3 enrichment and transcription of the osteoblast master gene Runx2/p57 in osteoblasts.J Cell Physiol2019
30443977Ethyl acetate and n-butanol fraction of Cissus quadrangularis promotes the mineralization potential of murine pre-osteoblast cell line MC3T3-E1 (sub-clone 4).J Cell Physiol2019
30515788RUNX1-dependent mechanisms in biological control and dysregulation in cancer.J Cell Physiol2019
30707485Participation of integrin β3 in osteoblast differentiation induced by titanium with nano or microtopography.J Biomed Mater Res A2019
30030171Gut-derived serotonin contributes to bone deficits in colitis.Pharmacol Res2019
30256410Mll-COMPASS complexes mediate H3K4me3 enrichment and transcription of the osteoblast master gene Runx2/p57 in osteoblasts.J Cell Physiol2019
30707485Participation of integrin β3 in osteoblast differentiation induced by titanium with nano or microtopography.J Biomed Mater Res A2019
30515788RUNX1-dependent mechanisms in biological control and dysregulation in cancer.J Cell Physiol2019
28926105Loss of RUNX1 is associated with aggressive lung adenocarcinomas.J Cell Physiol2018
28504305Intranuclear and higher-order chromatin organization of the major histone gene cluster in breast cancer.J Cell Physiol2018
28488769Selective expression of long non-coding RNAs in a breast cancer cell progression model.J Cell Physiol2018
28926105Loss of RUNX1 is associated with aggressive lung adenocarcinomas.J Cell Physiol2018
29968906Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity.J Cell Physiol2018
30002192Mitotic Gene Bookmarking: An Epigenetic Program to Maintain Normal and Cancer Phenotypes.Mol Cancer Res2018
30082484Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor.Mol Cancer Res2018
29759441Nuclear organization mediates cancer-compromised genetic and epigenetic control.Adv Biol Regul2018
29663383Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention.J Cell Physiol2018
29750276Thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling.Endocrinology2018
  • 1 - 50 of 1,176

Recommended Authors

University of Pittsburgh
Career Start Year 2015
Number of shared co-authors 0
Imperial College London
Career Start Year 2007
Number of shared co-authors 2
Charite-Universitatsmedizin Berlin
Career Start Year 2002
Number of shared co-authors 1
College of Biomedical Engineering, Taiyuan University of Technology
Career Start Year 1998
Number of shared co-authors 0
Guizhou Medical University
Career Start Year 1997
Number of shared co-authors 0
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 0
University of Navarra, Center for Applied Medical Research
Career Start Year 1995
Number of shared co-authors 0
Hokkaido University
Career Start Year 1994
Number of shared co-authors 0
Maastricht University
Career Start Year 1992
Number of shared co-authors 0
University of Michigan School of Medicine ann arbor
Career Start Year 1991
Number of shared co-authors 1
University of California, Los Angeles (university of california los angeles)
Career Start Year 1991
Number of shared co-authors 1
University of Texas Health San Antonio
Career Start Year 1990
Number of shared co-authors 1
University College London, UCL Cancer Institute
Career Start Year 1987
Number of shared co-authors 0
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1987
Number of shared co-authors 0
Center for Molecular Medicine, University of Georgia
Career Start Year 1986
Number of shared co-authors 2
Nantes Universite, Inserm UMR 7, CNRS UMR 6075, Universite d'Angers
Career Start Year 1986
Number of shared co-authors 0
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1986
Number of shared co-authors 0
Department of Oncology and Children's Research Center, University Children's Hospital
Career Start Year 1985
Number of shared co-authors 0
Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital
Career Start Year 1985
Number of shared co-authors 1
Imperial College London Hammersmith Hospital London UK.
Career Start Year 1983
Number of shared co-authors 2
Medical University of South Carolina
Career Start Year 1982
Number of shared co-authors 1
The University of Texas Health Science Center at Houston School of Dentistry
Career Start Year 1981
Number of shared co-authors 0
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 1980
Number of shared co-authors 0
Hollings Cancer Center, Medical University of South Carolina
Career Start Year 1979
Number of shared co-authors 0
Cardiovascular Research Institute, University of California san francisco
Career Start Year 1978
Number of shared co-authors 0
Merkin Institute for Translational Research, California Institute of Technology
Career Start Year 1976
Number of shared co-authors 2
University of Toronto
Career Start Year 1975
Number of shared co-authors 0
Cincinnati Children's Hospital Medical Center
Career Start Year 1975
Number of shared co-authors 0
Center for Coregulator Research, Baylor College of Medicine
Career Start Year 1964
Number of shared co-authors 1
University of California San Diego
Career Start Year 1963
Number of shared co-authors 1

Collaborators

University of Vermont
Co-authored papers 504
Co-authored papers 316
Co-authored papers 24
Co-authored papers 19
Co-authored papers 12
Co-authored papers 10
Co-authored papers 6
Tokyo Medical and Dental University (TMDU)
Co-authored papers 6
Yale Cancer Center and Smilow Cancer Hospital, Yale University School of Medicine
Co-authored papers 6
Tufts University School of Dental Medicine
Co-authored papers 4
Tufts University School of Dental Medicine
Co-authored papers 4
Co-authored papers 4
Maine Medical Center Research Institute
Co-authored papers 3
Co-authored papers 3
Shandong University
Co-authored papers 3
NASA Ames Research Center
Co-authored papers 3
Department of Food Bioengineering, Jeju National University
Co-authored papers 3
University of Massachusetts Chan Medical School
Co-authored papers 3
Harvard Medical School
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
California Institute of Technology
Co-authored papers 2
Co-authored papers 2
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 1
University of Sao Paulo
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1